Table 3.
Toxic effects and treatment-related mortality in the matched cohorts receiving induction therapy for AML
| Variable | CLDA (n = 95) |
IA (n = 95) |
P |
|---|---|---|---|
| Any grade <3 toxicity, no. (%) | 51 (54) | 36 (38) | .03 |
| Any grade ≥3 toxicity, no. (%) | 44 (46) | 59 (62) | |
| TRM rate at 4 weeks | 5% | 11% | .42 |
| TRM rate at 8 weeks | 14% | 15% | .84 |
TRM, treatment-related mortality.